In the News

Research advances from the National Institutes of Health (NIH) Intramural Research Program (IRP) often make headlines. Read the news releases that describe our most recent findings:

Featured Article

NIH study shows promising immune cell response against some Covid variants that could be good news for vaccines

Tuesday, March 30, 2021

A type of T-cell responsible for destroying cells infected with virus was able to recognize three Covid-19 variants in a small U.S. study, a promising sign that the vaccines should still protect against new, emerging strains, researchers at the National Institute of Allergy and Infectious Diseases said Tuesday.

Researchers, led by NIAID staff scientist Andrew Redd, investigated whether T cells found in blood samples of patients who recovered from the original strain of the virus recognized B.1.1.7, the variant first detected in the U.K., B.1.351, originally found in South Africa, and P.1, first seen in Brazil. The NIAID is part of the National Institutes of Health, which published the study.


Continue Exploring the IRP